JNJ-64264681

Also Known As:

7-(4-methyl-6-(2-methylpropyl)pyridin-3-yl)-6-oxo-N-((1R,2S)-2-(prop-2-enoylamino)cyclopentyl)-2-thia-5,7,11-triazatricyclo(6.3.1.04,12)dodeca-1(11),3,8(12),9-tetraene-3-carboxamide

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Aza Compounds: 3
  - JNJ-64264681: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - JNJ-64264681: 1

Related Diseases

1.	Neoplasms (Cancer) 11/10/2022 - "JNJ-64264681 demonstrated excellent oral efficacy in both cancer and autoimmune models with sustained in vivo target coverage amenable to once daily dosing and has advanced into human clinical studies to investigate safety and pharmacokinetics."